Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #669007 on NorthWest Biotherapeutics Inc (NWBO)
flipper44
01/31/24 1:56 PM
#669017 RE: exwannabe #669007
Accelerated approval process. From 2024, the MHRA will also implement a “swift approval process” for the most impactful new medicines and technologies, such as “cancer vaccines and AI therapeutics for mental health.” https://www.insideeulifesciences.com/2023/03/20/uk-mhra-to-recognize-foreign-regulatory-approvals-for-medicines-and-medical-technologies-and-promote-digital-innovation/
“From 2024, MHRA will move to a different model which allow rapid, often near automatic sign-off for medicines and technologies already approved by trusted regulators in other parts of the world such as the United States, Europe or Japan.” ”At the same time from next year they will set up a swift new approval process for the most cutting edge medicines and devices to ensure the UK becomes a global centre for their development.” Dr. Laura Squire https://www.gov.uk/government/news/mhras-new-chief-healthcare-quality-and-access-officer-begins-important-role